Story · Medicine & Biotech

Beyond Conventional CRISPR

1 outlet · first reported by GEN Genetic Engineering News 6d ago

Coverage, in order

  1. 6d ago
    GEN Genetic Engineering News indie
    Beyond Conventional CRISPR

    In December 2023, the FDA approved the first CRISPR-based treatment in the United States for sickle cell disease. 1 Despite this advance, conventional CRISPR-Cas9 systems may introduce potentially harmful DNA breaks and cannot easily be delivered to muscle and brain cells. Moreover, genome editing…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.